Clinical Trials
2
Active:0
Completed:1
Trial Phases
1 Phases
Phase 1:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)โข Click on a phase to view related trials
Phase 1
2 (100.0%)A Study of ORTD-1 in Patients Hospitalized With COVID-19 Related Pneumonia
Phase 1
Withdrawn
- Conditions
- COVID-19
- Interventions
- Other: Vehicle controlDrug: ORTD-1 low doseDrug: ORTD-1 mid doseDrug: ORTD-1 high dose
- First Posted Date
- 2021-01-13
- Last Posted Date
- 2021-06-14
- Lead Sponsor
- Oryn Therapeutics, LLC
- Registration Number
- NCT04708236
- Locations
- ๐บ๐ธ
UC Irvine Medical Center, Orange, California, United States
Randomized, Double-blind, Vehicle Controlled, Repeat Dose Comparative Study in RA Patients Managed With DMARDs
Phase 1
Completed
- Conditions
- Rheumatoid Arthritis
- Interventions
- Drug: Low dose vehicle controlDrug: High dose vehicle controlDrug: Low dose ORTD-1Drug: High dose ORTD-1
- First Posted Date
- 2020-02-27
- Last Posted Date
- 2021-10-19
- Lead Sponsor
- Oryn Therapeutics, LLC
- Target Recruit Count
- 17
- Registration Number
- NCT04286789
- Locations
- ๐บ๐ธ
Keck School of Medicine of USC Division of Rheumatology, Los Angeles, California, United States
๐บ๐ธOrange County Research Center, Tustin, California, United States
๐บ๐ธAdvanced Pharma CR, LLC, Miami, Florida, United States
News
No news found